project id: TCGA-PRAD; case submitter id: TCGA-ZG-A8QW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.24; rna integrity number: 8.0; age at index: 72; days to birth: -26632; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 26632; ajcc clinical m: M0; ajcc clinical t: T3a; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 94.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 156; initial weight: 270.0; sample id: ef5058a4-054d-4fd2-876d-d3247d391c1b; sample submitter id: TCGA-ZG-A8QW-01A; portion id: d2feef3b-a5e8-4c5d-a34d-f262dc8f6b32; portion submitter id: TCGA-ZG-A8QW-01A-11; slide id: 0c287a6f-f314-4dba-8c57-09e6d58c88ad; slide submitter id: TCGA-ZG-A8QW-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; section location: TOP;